The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
CCTG HN.10: A phase II single-arm trial of elective volume adjusted de-escalation radiotherapy (EVADER) in patients with low-risk HPV-related oropharyngeal squamous cell carcinoma (NCT03822897).
 
Scott Victor Bratman
Consulting or Advisory Role - Bristol-Myers Squibb
Research Funding - Nektar
Patents, Royalties, Other Intellectual Property - Co-inventor and holder of a patent related to circulating tumor DNA detection technology.
Travel, Accommodations, Expenses - AstraZeneca
 
Eric Berthelet
No Relationships to Disclose
 
James B. Butler
No Relationships to Disclose
 
John R de Almeida
No Relationships to Disclose
 
Irene Karam
No Relationships to Disclose
 
Ur Metser
Consulting or Advisory Role - POINT Biopharma
 
Robert Anton Olson
No Relationships to Disclose
 
Craig Pochini
No Relationships to Disclose
 
John Waldron
No Relationships to Disclose
 
Eugene Yu
No Relationships to Disclose
 
Andrea McNiven
No Relationships to Disclose
 
Winson Y. Cheung
No Relationships to Disclose
 
Marc Gaudet
No Relationships to Disclose
 
Sarah Hunter
No Relationships to Disclose
 
Bingshu E. Chen
No Relationships to Disclose
 
Wendy R. Parulekar
No Relationships to Disclose